Authors:
Celentano, DD
Galai, N
Sethi, AK
Shah, NG
Strathdee, SA
Vlahov, D
Gallant, JE
Citation: Dd. Celentano et al., Time to initiating highly active antiretroviral therapy among HIV infectedinjection drug users, AIDS, 15(13), 2001, pp. 1707-1715
Citation: Jn. Blankson et al., Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution, J INFEC DIS, 183(4), 2001, pp. 657-661
Authors:
Haas, DW
Arathoon, E
Thompson, MA
Pedro, RD
Gallant, JE
Uip, DE
Currier, J
Noriega, LM
Lewi, DS
Uribe, P
Benetucci, J
Cahn, P
Paar, D
White, CA
Collier, AC
Ramirez-Ronda, CH
Harvey, C
Chung, M
Mehrotra, D
Chodakewitz, J
Nguyen, BY
Citation: Dw. Haas et al., Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine, AIDS, 14(13), 2000, pp. 1973-1978
Authors:
Powderly, WG
Gallant, JE
Ghannoum, MA
Mayer, KH
Navarro, EE
Perfect, JR
Citation: Wg. Powderly et al., Oropharyngeal candidiasis in patients with HIV: Suggested guidelines for therapy, AIDS RES H, 15(18), 1999, pp. 1619-1623
Authors:
Hall, CS
Raines, CP
Barnett, SH
Moore, RD
Gallant, JE
Citation: Cs. Hall et al., Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens, AIDS, 13(10), 1999, pp. 1207-1212